US 11,939,631 B2
Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
Jingyue Ju, Englewood Cliffs, NJ (US); Dae Hyun Kim, Northbrook, IL (US); Lanrong Bi, Hancock, MI (US); Qinglin Meng, Foster City, CA (US); and Xiaoxu Li, New York, NY (US)
Assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US)
Filed by The Trustees of Columbia University in the City of New York, New York, NY (US)
Filed on Aug. 18, 2021, as Appl. No. 17/405,341.
Application 17/405,341 is a continuation of application No. 16/722,702, filed on Dec. 20, 2019, granted, now 11,098,353.
Application 16/722,702 is a continuation of application No. 15/988,321, filed on May 24, 2018, abandoned.
Application 15/988,321 is a continuation of application No. 15/354,531, filed on Nov. 17, 2016, granted, now 10,000,801, issued on Jun. 19, 2018.
Application 15/354,531 is a continuation of application No. 14/242,487, filed on Apr. 1, 2014, granted, now 9,528,151, issued on Dec. 27, 2016.
Application 14/242,487 is a continuation of application No. 13/665,588, filed on Oct. 31, 2012, abandoned.
Application 13/665,588 is a continuation of application No. 13/023,283, filed on Feb. 8, 2011, granted, now 8,298,792, issued on Oct. 30, 2012.
Application 13/023,283 is a continuation of application No. 12/312,903, granted, now 7,883,869, issued on Feb. 8, 2011, previously published as PCT/US2007/024646, filed on Nov. 30, 2007.
Claims priority of provisional application 60/872,240, filed on Dec. 1, 2006.
Prior Publication US 2021/0381043 A1, Dec. 9, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. C12Q 1/68 (2018.01); C12Q 1/6823 (2018.01); C12Q 1/6869 (2018.01)
CPC C12Q 1/6869 (2013.01) [C12Q 1/6823 (2013.01)] 5 Claims
 
1. A plurality of different deoxyribonucleic acids covalently immobilized on a solid support, wherein at least one of the plurality different deoxyribonucleic acids comprises a polymerase-incorporated labeled nucleotide analogue derived from the group consisting of labeled nucleotide analogues A-D, and wherein at least one of the plurality of different deoxyribonucleic acids comprises a polymerase-incorporated un-labeled nucleotide analogue derived from the group consisting of un-labeled nucleotide analogues A′-D′

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
wherein R (a) represents a cleavable, chemical group capping the oxygen at the 3′ position of the deoxyribose of the deoxyribonucleotide analogue, (b) does not interfere with recognition of the analogue as a substrate by the DNA polymerase or with incorporation of the analogue into the growing DNA strand during the DNA polymerase reaction, and (c) is stable during the DNA polymerase reaction;
wherein the covalent bona between the 3′-oxygen and R is stable during the DNA polymerase reaction;
wherein each of Dye 1, Dye 2, Dye 3 and Dye 4 represents a distinguishable, detectable moiety;
wherein (i) the nucleotide analogue is incorporated into the growing DNA strand as a result of the DNA polymerase reaction, (ii) the incorporated analogue is identified, and (iii) the covalent bond between the 3′-oxygen and R is cleaved under conditions compatible with DNA sequencing to allow the incorporation and detection of the next nucleotide analogue;
wherein Y represents a cleavable, chemical linker which (a) does not interfere with recognition of the analogue as a substrate by the DNA polymerase or with incorporation of the analogue into the growing DNA strand during the DNA polymerase reaction and (b) is stable during the DNA polymerase reaction;
wherein the nucleotide analogue:
i) is recognized as a substrate by the DNA polymerase for incorporation into the growing′ DNA strand during the DNA polymerase reaction,
ii) is efficiently and accurately incorporated at the end of the growing DNA strand during the DNA polymerase reaction,
iii) produces a 3′—OH group on the deoxyribose upon cleavage of R under conditions compatible with DNA sequencing, and
iv) no longer includes a detectable moiety on the base upon cleavage of Y under conditions compatible with DNA sequencing;
and wherein if the nucleotide analogue is: (A) or (A′), it forms hydrogen bonds with cytosine or a cytosine nucleotide analogue; (B) or (B′), it forms hydrogen bonds with thymine or a thymine nucleotide analogue; (C) or (C′), it forms hydrogen bonds with guanine or a guanine nucleotide analogue, or (D) or (D′), it forms hydrogen bonds with adenine or an adenine nucleotide analogue.